Author

R M du Bois

Observed names: DU BOIS R, DUBOIS, R, DUBOIS, RM, Du Bois, RM, DuBois R. M., Dubois, RM, R DuBois, R. M. DUBOIS, R. M. Du Bois, R. M. Dubois, R. M. duBois, R.M duBois, R.M. DUBOIS, R.M. Dubois, R.M. duBois, RM duBois, ROLAND DUBOIS, ROLAND M. DUBOIS, Roland M duBois, Roland M. Dubois, Roland M. duBois, Roland duBois, Ron duBois, Ronald M du Bois, Ronald M. du Bois, du Bois, RM, du Bois, RM, duBois, R, duBois, RM

Observed institutions: University of Southern California, Cleveland Clinic, Mayo Clinic, Medical University of South Carolina, Maastricht University Medical Centre, The Royal Free Hospital, National Jewish Health, Royal Brompton Hospital, Mayo Clinic in Arizona, Imperial College London, The University of Texas Southwestern Medical Center, University of Colorado Denver

OpenAlex ID: A5113852575

Epithelial Origin of Myofibroblasts during Fibrosis in the Lung

2006 · Brigham C. Willis, Roland M. duBois, et al. · Proceedings of the American Thoracic Society · 500

The Prognostic Significance of the Histologic Pattern of Interstitial Pneumonia in Patients Presenting with the Clinical Entity of Cryptogenic Fibrosing Alveolitis

2000 · ANDREW G. NICHOLSON, THOMAS V. COLBY, et al. · American Journal of Respiratory and Critical Care Medicine · 489

Treatment of Sarcoidosis

2008 · Robert P. Baughman, Ulrich Costabel, et al. · Clinics in Chest Medicine · 206

Role of Endoplasmic Reticulum Stress in Epithelial–Mesenchymal Transition of Alveolar Epithelial Cells

2010 · Qian Zhong, Beiyun Zhou, et al. · American Journal of Respiratory Cell and Molecular Biology · 200

Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection

2003 · P Kumar, P Goldstraw, et al. · Journal of Thoracic and Cardiovascular Surgery · 197

PDF

Role of thrombin in pulmonary fibrosis

1995 · N.A. Hernández-Rodríguez, A.D. Cambrey, et al. · The Lancet · 154

Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis

1991 · D.C. Briggs, R.W. Vaughan, et al. · The Lancet · 136

Serial Circulating Adhesion Molecule Levels Reflect Disease Severity in Systemic Sclerosis

1995 · C. P. DENTON, M. C. M. BICKERSTAFF, et al. · Lara D. Veeken · 128

Immunohistochemical localization of transforming growth factor‐β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders

1994 · B. CORRIN, D. BUTCHER, et al. · Histopathology · 115

KL‐6 levels are elevated in plasma from patients with acute respiratory distress syndrome

2003 · H. Sato, M.E.J. Callister, et al. · European Respiratory Journal · 114

PDF

HLA-DP Allele-Specific T Cell Responses to Beryllium Account for DP-Associated Susceptibility to Chronic Beryllium Disease

2001 · Giovanna Lombardi, Conrad Germain, et al. · The Journal of Immunology · 107

PDF

Randomized, Double-blind, Placebo-controlled Trial of Infliximab in Patients With Chronic Pulmonary Sarcoidosis

2005 · R.P. Baughman, M.A. Judson, et al. · CHEST Journal · 92

PDF

High Beryllium-stimulated TNF- α Is Associated with the − 308 TNF- α Promoter Polymorphism and with Clinical Severity in Chronic Beryllium Disease

2001 · LISA A. MAIER, RICHARD T. SAWYER, et al. · American Journal of Respiratory and Critical Care Medicine · 56

Increased sensitivity of the cough reflex in progressive systemic sclerosis patients with interstitial lung disease

1998 · UG Lalloo, S Lim, et al. · European Respiratory Journal · 54

Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis

1992 · S. J. Garber, A. U. Wells, et al. · British Journal of Radiology · 38

The importance of sarcoidosis genotype to lung phenotype.

2003 · Jan C Grutters, Hiroe Sato, et al. · PubMed · 34

Alveolar Macrophages and T Cells from Sarcoid, but Not Normal Lung, Are Permissive to Adenovirus Infection and Allow Analysis of NF- κ B–Dependent Signaling Pathways

2001 · Matthew Conron, Jan Bondeson, et al. · American Journal of Respiratory Cell and Molecular Biology · 33

Cytoplasmic deposition of NFκB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation

2002 · U Griesenbach, RL Cassady, et al. · Gene Therapy · 27

Nuclear Factor- κ B Activation in Alveolar Macrophages Requires I κ B kinase- β, but Not Nuclear Factor- κ B Inducing Kinase

2002 · Matthew Conron, Evangelos Andreakos, et al. · American Journal of Respiratory and Critical Care Medicine · 18

The Density of HLA-DR Antigen Expression on Alveolar Macrophages is Increased in Pulmonary Sarcoidosis

1986 · D.A. Campbell, R.M. Dubois, et al. · Clinical Science · 18

Genetic and Environmental Risk Factors in Beryllium Sensitization and Chronic Beryllium Disease

2002 · Lisa Maier, John Martyny, et al. · CHEST Journal · 16

Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis.

2008 · Maria Teresa Carulli, Paolo Spagnolo, et al. · PubMed · 11

Longitudinal Trends in Dyspnea in Patients With Idiopathic Pulmonary Fibrosis (ipf): the Build 1 Study

2006 · Jeff Swigris, Juergen Behr, et al. · CHEST Journal · 8

Assessment of Infliximab Efficacy in Extrapulmonary Sarcoidosis Using a Novel Assessment Tool: Results From a Randomized Trial

2005 · M.A. Judson, U. Costabel, et al. · CHEST Journal · 7

PDF

Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the Modern Era

2011 · Steven D. Nathan, Oksana A. Shlobin, et al. · 4

Works count: 48

Citation count: 2,768

H-index: 18

I10-index: 22